Coumestrol Triggers Ferroptosis in RA Synoviocytes via PMAIP
2026-07-19
This study demonstrates that Coumestrol, a phytoestrogen and estrogen receptor antagonist, induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes by stabilizing mitochondrial PMAIP1 through TRIM3 inhibition. The findings suggest a novel cell death mechanism for controlling synovial hyperplasia and inflammation, providing a mechanistic basis for further research into selective estrogen receptor modulators in autoimmune disease models.
Phenothiazines Enhance Macrophage Antibacterial Activity via
2026-07-18
The referenced study demonstrates that phenothiazines, including perphenazine, significantly enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) production and autophagy. These findings highlight a promising host-directed approach to combating antibiotic-resistant and intracellular bacterial infections.
A-769662: Precision AMPK Activator for Metabolic Research
2026-07-17
A-769662 is a potent, reversible AMPK activator with submicromolar EC50, widely used to dissect energy metabolism and fatty acid synthesis inhibition. Unlike earlier models, recent evidence reveals that AMPK activation by A-769662 suppresses autophagy initiation, refining its research applications.
LINC02613 Drives OSCC Metastasis via LCP1 Ubiquitination Dis
2026-07-17
This study identifies LINC02613 as a key long noncoding RNA that promotes oral squamous cell carcinoma (OSCC) metastasis by interfering with LCP1 ubiquitination and degradation. Targeted delivery of siLINC02613 using pH-responsive nanoparticles effectively inhibited OSCC progression, highlighting a promising molecular target for therapeutic intervention.
Eltanexor (KPT-8602): Optimizing Nuclear Export Inhibition i
2026-07-16
Eltanexor (KPT-8602) enables robust, targeted inhibition of XPO1 for leukemia and colorectal cancer research, offering superior tolerability and mechanistic clarity. This guide details workflow enhancements, protocol tips, and troubleshooting strategies to maximize reproducibility and translational impact.
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-07-16
This study reveals that naturally occurring angiotensin peptide fragments, particularly N-terminally truncated forms like Angiotensin 1/2 (2-7), can significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide new insights into the intersection of renin-angiotensin signaling and viral entry mechanisms, with implications for both cardiovascular and infectious disease research.
EZ Cap™ OVA mRNA: Designing Next-Gen Immune Models with Safe
2026-07-15
Explore how advances in mRNA capping and next-generation lipid nanoparticle systems, exemplified by EZ Cap™ OVA mRNA, are transforming immunology research. This article bridges mechanistic insight, translational workflow guidance, and the latest evidence on minimizing inflammatory side effects, providing strategic direction for researchers seeking robust, reproducible, and clinically relevant immune modeling solutions.
Losartan in Translational Research: Mechanism, Opportunity,
2026-07-15
This thought-leadership article explores Losartan’s mechanistic role as a selective angiotensin II type 1 (AT1) receptor antagonist and its expanding applications in cardiovascular and tumor microenvironment research. It connects molecular insights with strategic guidance for translational scientists, referencing recent discoveries on Losartan’s impact in immune checkpoint blockade synergy, and provides actionable protocol guidance rooted in evidence. The discussion uniquely bridges established cardiovascular research with emerging oncology frontiers, emphasizing APExBIO Losartan’s value in enabling robust, reproducible experiments and advancing therapeutic innovation.
HyperScribe T7 High Yield RNA Synthesis Kit Plus: Precision
2026-07-14
The HyperScribe T7 High Yield RNA Synthesis Kit Plus delivers robust, high-yield RNA production, empowering translational research from mRNA therapeutics to probe-based assays. Its workflow flexibility and advanced troubleshooting set it apart for applications demanding reliable in vitro transcription and custom RNA modification.
Proliferation Tracing Mouse Model Illuminates Breast Cancer
2026-07-14
This study introduces a dual recombinase-based genetic mouse model for selectively tracing and ablating proliferating cells in spontaneous mammary tumors. By enabling detailed analysis of relapse mechanisms, the model provides new insights into tumor heterogeneity, cancer stem cell dynamics, and microenvironmental remodeling relevant to breast cancer therapy resistance.
Tranexamic Acid as an Antifibrinolytic Agent: Protocols & In
2026-07-13
Tranexamic Acid is redefining antifibrinolytic workflows, facilitating instant clot formation and robust infection control in translational wound care research. Explore optimized protocols, comparative assay strategies, and troubleshooting insights leveraging high-purity Tranexamic Acid from APExBIO.
Plant Molluscicides: Hagenia abyssinica Extracts Target Snai
2026-07-13
This study rigorously evaluated extracts of Hagenia abyssinica, Rosa abyssinica, and Cucumis ficifolius for their molluscicidal activity against schistosomiasis-transmitting snails. The findings highlight the potent, selective action of H. abyssinica extracts, supporting its promise as a biodegradable alternative for vector control and laying groundwork for future isolation of active compounds.
Dissecting ampC/ampD Mutations Driving Ceftolozane-Tazobacta
2026-07-12
This study leverages semi-mechanistic PKPD modeling to clarify how specific ampC and ampD mutations in Pseudomonas aeruginosa drive resistance to ceftolozane-tazobactam and alter imipenem susceptibility. The findings provide a framework for distinguishing initial and adaptive resistance mechanisms, advancing the precision of antibiotic resistance assays.
Applied Workflows with (-)-Norepinephrine (+)-bitartrate
2026-07-10
(-)-Norepinephrine (+)-bitartrate enables precise and reproducible cardiovascular and adrenergic signaling studies, thanks to its validated receptor selectivity and robust vasoconstrictive properties. This guide unpacks actionable workflows, troubleshooting tips, and the latest data-driven insights to ensure optimal results in cardiomyopathy research and blood pressure regulation.
Nifedipine (BAY-a-1040): Precision Calcium Influx Inhibition
2026-07-09
Nifedipine (BAY-a-1040) from APExBIO stands out as a potent and selective L-type calcium channel blocker, enabling high-fidelity exploration of calcium-dependent processes in both cellular and cross-domain metabolic studies. Its applications span from dissecting cardiac insufficiency mechanisms to unraveling iron metabolism and fungal pathogen responses, with robust troubleshooting and workflow enhancements for reproducible results.
468 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page